Betaphlem Syrup
PDF Leaflet Revision Date: 31 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunctive therapy in respiratory tract disorders with excessive viscous mucous.
Dosage (summary)
Adults: 10-15 ml three times daily; Children 6-12 years: 5 ml three times daily; Children 2-5 years: 1.25-2.5 ml four times daily.
Special Populations
- History of peptic ulcer
- Asthmatic patients
- Severe respiratory failure
- Debilitated patients
Pregnancy & Breastfeeding
Safety in pregnancy not established; unknown if excreted in breast milk.
Key Drug Interactions
- Incompatible with pholcodeine linctus
Contraindications
- Hypersensitivity to carbocisteine
- Active peptic ulcer
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Headache
- Dizziness
Counselling Points
- Avoid in children under 2 years
- Contains sucrose; caution in patients with fructose intolerance
Serious warnings
- Caution in patients with a history of peptic ulcer
- Risk of airway obstruction due to increased secretions
Important Disclaimer
The Betaphlem Syrup professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
